Concordia International Announces Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Funds sell $44bn in semiconductors on AI concerns
Concordia (CXRX) Reports Cross Currency Swap Agreement
August 15, 2016 1:17 PM EDTConcordia International Corp. (NASDAQ: CXRX) together with its subsidiaries ("Concordia") - an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, today announced that it has entered into a cross currency swap agreement (the "Swap Agreement").
As previously disclosed, Concordia was actively evaluating... More
GMP Securities Downgrades Concordia Healthcare (CXRX) to Hold
August 15, 2016 8:23 AM EDTGMP Securities downgraded Concordia Healthcare (NASDAQ: CXRX) from Buy to Hold.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $10.13 yesterday.
... MoreCIBC Downgrades Concordia Healthcare (CXRX) to Sector Underperform
August 15, 2016 8:18 AM EDTCIBC downgraded Concordia Healthcare (NASDAQ: CXRX) from Sector Perform to Sector Underperform with a price target of $7.80.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $10.13 yesterday.
... MoreRBC Capital Cuts PT on Concordia Int'l (CXRX) to $27 Following Q2 REsults
August 15, 2016 6:27 AM EDTRBC Capital lowers its price target on Outperform-rated Concordia International (Nasdaq: CXRX) from $33 down to $27 following Q2 results last week.
The firm commented, Although we had recently revised our forecasts to reflect FX impact post-Brexit and weakness in the U.S. legacy... More
RBC Affirms Concordia (CXRX) at 'Outperform' as Q2 Profit Meets Lowered Expectations
August 12, 2016 9:24 AM EDTRBC Capital is out with initial commentary on Concordia International (Nasdaq: CXRX) following Q2 results and other matters announced earlier. The firm rates CXRX at Outperform wth a price target of $33.
Analyst Douglas Miehm commented, CXRX's Q2 results, which faced lower expectations from... More
Concordia Healthcare (CXRX) Misses Q2 EPS by 4c; CFO de Saldanha to Resign; Dividend Suspended
August 12, 2016 7:03 AM EDTConcordia Healthcare (NASDAQ: CXRX) reported Q2 EPS of $1.38, $0.04 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $231.7 million versus the consensus estimate of $229.76 million.
Management Changes and Suspension of Dividend
The Company announced today that Adrian de Saldanha, Concordia's Chief Financial Officer, will be... More
